期刊文献+

骨髓基质细胞在中枢神经系统疾病基因治疗中的应用

Applications of Bone Marrow Stromal Cells in Gene lherapy of Central Nervous System Diseases
原文传递
导出
摘要 基因治疗是指将人的正常基因或有治疗作用的基因通过一定方式导入人体靶细胞,以纠正基因缺陷或发挥治疗作用,从而达到治疗疾病的目的。骨髓基质细胞是一种具有自我更新和多向分化潜能的干细胞,易于体外扩增,并且可在体内外表达多种治疗性外源基因。因此,骨髓基质细胞被认为是细胞治疗和基因治疗的一种理想靶细胞。本文对骨髓基质细胞的生物学特性、常用基因治疗载体及其在中枢神经系统疾病基因治疗中的应用做一综述。 Gene therapy refers to the introduction of normal genes into human target cells for correcting gene defects or exerting therapeutic action, and thus achieves the goal of treatment of disease. Bone marrow stromal cells (BMSCs) are stem cells that possess self-renewal and multi-directional differentiation potential and easy to amplify in vitro, and they also express many therapeutic exogenous genes in vitro or in vivo. So BMSCs have been regarded as an ideal target cell of cell and gene therapy, This article reviews the biological characteristic of BMSCs, some commonly used gene therapy vectors and their applications in gene therapy of central nervous system diseases.
出处 《国际脑血管病杂志》 2008年第2期131-136,共6页 International Journal of Cerebrovascular Diseases
关键词 骨髓基质细胞 基因治疗 中枢神经系统疾病 bone marrow stromal cell gene therapy nervous system disease
  • 相关文献

参考文献47

  • 1Haas S, Weidner N, Winkler J. Adult stem cell therapy in stroke. Curr Opin Neurol, 2005, 18:59 -64.
  • 2Li Y, Chen J, Wang L, et al. Intracerebral transplanlation of bone marrow stromal cells in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. Neurosci Lett, 2001,316:67 - 70.
  • 3Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 1997, 276:71 - 74.
  • 4Tuan RS, Boland G, Tuli R. Adult mesenchymal stem cells and cell-bated tissue engineering. Arthritis Res Ther. 2003.5:32 -45.
  • 5Mankani MH, Kuznetsov SA, Shannon B, et al. Canine cranial reconstruction using autologous bone marrow stromal cells. Am J Pathol, 2006, 168: 542- 550.
  • 6Schwarz FJ, Alexander GM, Prockop DJ, et al. Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. Hum Gene Ther, 1999, 10:2539 - 2549.
  • 7Park KW, Eglitis MA, Mouradian MM. Protection of nigral neurons by GDNF-engineered marrow cell transplantation. Neurosci Res, 2001, 40:315 -323.
  • 8Zhang Y, Lin HK, Frimberger D, et al. Growth of bone marrow stromal cells on small intestinal submucosa: an alternative cell source for tissue engineered bladder. BJU Int, 2005, 96:1120 - 1125.
  • 9Azizi SA, Stokes D, Augelli BJ, et al. Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats-similarities to astrocyte grafts. Proc Natl Acad Sci USA, 1998, 95:3908 -3913.
  • 10Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA, 1999, 96:10711 - 10716.

二级参考文献17

  • 1李中,张成,谢有梅,陈国俊,刘晓蓉.骨髓间质干细胞移植治疗DMD模型鼠的肌组织dystrophin/utrophin表达[J].中国医学科学院学报,2004,26(3):294-297. 被引量:7
  • 2常津.具有复合靶向抗癌功能的纳米高分子材料[J].中国生物医学工程学报,1996,15(2):97-101. 被引量:44
  • 3常津.纳米高分子材料在抗癌药物控释方面的应用[J].中国生物医学工程学报,1996,15(2):102-106. 被引量:10
  • 4Pierre Lehn, Sylvie Fabrega, Noufissa Oudrhiri, et al. Gene delivery systems: Bridging the gap between recombinant viruses and artificial vectors[J]. Adv. Drug Delve. Rev,1998,30:5-11.
  • 5Truong Le, Walsh, Scott M, et al. Gene transfer by DNA-gelatin nanospheres[J]. Arch Biochem Biophys, 1999,361(1):47-56.
  • 6Colin W. Pouton, Leonard W. Seymour. Key issues in non-viral gene delivery[J]. Adv Drug Delve. Rev,1998,34(1):3-19.
  • 7Cristiano, Richard J. Targeted, non-viral gene delivery for cancer gene therapy[J]. Front. Biosci, 1998,3:D1161-D1170.
  • 8Meirelles Lda S,Nardi NB.Murine marrow-derived mesenchymal stem cell:isolation,in vitro expansion,and characterization.Br J Haematol,2003,123(4):702-711.
  • 9Ahn AH,Kunkel LM.The structural and functional diversity of dystrophin.Nature Genetics,1993,3(4):183-291.
  • 10Harper SQ,Hauser MA,Dello Russo C,et al.Modular flexibility of dystrophin:implications for gene therapy of Duchenne muscular dystrophy.Nat Med,2002,8 (3):253-261.

共引文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部